290 related articles for article (PubMed ID: 36220808)
1. Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.
Pinzón-Espinosa J; van der Horst M; Zinkstok J; Austin J; Aalfs C; Batalla A; Sullivan P; Vorstman J; Luykx JJ
Transl Psychiatry; 2022 Oct; 12(1):442. PubMed ID: 36220808
[TBL] [Abstract][Full Text] [Related]
2. Clinicians' perceptions of pharmacogenomics use in psychiatry.
Chan CY; Chua BY; Subramaniam M; Suen EL; Lee J
Pharmacogenomics; 2017 Apr; 18(6):531-538. PubMed ID: 28290747
[TBL] [Abstract][Full Text] [Related]
3. Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk.
Palk AC; Dalvie S; de Vries J; Martin AR; Stein DJ
Philos Ethics Humanit Med; 2019 Feb; 14(1):4. PubMed ID: 30813945
[TBL] [Abstract][Full Text] [Related]
4. The ethics of polygenic scores in psychiatry: minefield or opportunity for patient-centered psychiatry?
Wouters RHP; van der Horst MZ; Aalfs CM; Bralten J; Luykx JJ; Zinkstok JR
Psychiatr Genet; 2024 Apr; 34(2):31-36. PubMed ID: 38441147
[TBL] [Abstract][Full Text] [Related]
5. Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine.
Eeltink E; van der Horst MZ; Zinkstok JR; Aalfs CM; Luykx JJ
Neurosci Biobehav Rev; 2021 Feb; 121():119-127. PubMed ID: 33301779
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
[TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
8. Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.
Murray GK; Lin T; Austin J; McGrath JJ; Hickie IB; Wray NR
JAMA Psychiatry; 2021 Feb; 78(2):210-219. PubMed ID: 33052393
[TBL] [Abstract][Full Text] [Related]
9. Knowledge, Attitudes, and Perceived Barriers toward Genetic Testing and Pharmacogenomics among Healthcare Workers in the United Arab Emirates: A Cross-Sectional Study.
Rahma AT; Elsheik M; Ali BR; Elbarazi I; Patrinos GP; Ahmed LA; Al Maskari F
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33182317
[TBL] [Abstract][Full Text] [Related]
10. Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.
Brown L; Eum S; Haga SB; Strawn JR; Zierhut H
Pharmacopsychiatry; 2020 Jul; 53(4):162-173. PubMed ID: 31509860
[TBL] [Abstract][Full Text] [Related]
11. Polygenic risk scores in psychiatry: Will they be useful for clinicians?
Fullerton JM; Nurnberger JI
F1000Res; 2019; 8():. PubMed ID: 31448085
[TBL] [Abstract][Full Text] [Related]
12. Psychiatrists' attitudes regarding genetic testing and patient safeguards: a preliminary study.
Hoop JG; Roberts LW; Green Hammond KA; Cox NJ
Genet Test; 2008 Jun; 12(2):245-52. PubMed ID: 18452395
[TBL] [Abstract][Full Text] [Related]
13. Perception and knowledge of pharmacogenetics among Brazilian psychiatrists.
Almeida BC; Gonçalves ED; de Sousa MH; Osis MJMD; de Brito Mota MJB; Planello AC
Psychiatry Res; 2021 Dec; 306():114238. PubMed ID: 34656849
[TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
15. Predictive and diagnostic genetic testing in psychiatry.
Mitchell PB; Meiser B; Wilde A; Fullerton J; Donald J; Wilhelm K; Schofield PR
Psychiatr Clin North Am; 2010 Mar; 33(1):225-43. PubMed ID: 20159347
[TBL] [Abstract][Full Text] [Related]
16. Implementation of Therapeutic Virtual Reality Into Psychiatric Care: Clinicians' and Service Managers' Perspectives.
Chung OS; Robinson T; Johnson AM; Dowling NL; Ng CH; Yücel M; Segrave RA
Front Psychiatry; 2021; 12():791123. PubMed ID: 35058823
[No Abstract] [Full Text] [Related]
17. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
[TBL] [Abstract][Full Text] [Related]
18. Application of the COM-B model to barriers and facilitators to chlamydia testing in general practice for young people and primary care practitioners: a systematic review.
McDonagh LK; Saunders JM; Cassell J; Curtis T; Bastaki H; Hartney T; Rait G
Implement Sci; 2018 Oct; 13(1):130. PubMed ID: 30348165
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.
Shishko I; Almeida K; Silvia RJ; Tataronis GR
Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610
[TBL] [Abstract][Full Text] [Related]
20. Attitudes Toward Psychiatric Genetic Testing and Research: A Comparative Study Between Denmark and Cuba.
Sundby A; Marcheco-Teruel B; Monzón-Benítez G; Fuentes-Smith E; Laegsgaard Madsen MM; Mors O
Genet Test Mol Biomarkers; 2019 Dec; 23(12):857-864. PubMed ID: 31718291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
